Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

NCT03899155 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT03899155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 2
Overall status
Recruiting
Start date
August 9, 2019
Completion date
August 25, 2029
Enrollment
1,500 (estimated)
Sites
399

Conditions

As the registry lists them; a condition with its own page is linked.

cancer